Please login to the form below
Infographic: Pharma investment in Indonesia
Pharma deals in the region since the introduction of Decree 1010 to force companies to manufacture products locally
In 2008, the government in Indonesia released Decree 1010, meaning all foreign pharma companies working in the country had to manufacture drugs locally or form a partnership with a local manufacturer in order to register their own medicines.
This infographic details all the agreements formed by pharma companies in the region in the five years since Decree 1010 was published.
The affected pharma companies are MSD, Sanofi, Servier, AstraZeneca, Novo Nordisk, Lilly, Janssen- Cilag, Astellas, Wyeth, Roche and PT Orshonovo.
Read the accompanying article on pharma investment in Indonesia
2013: Five years after Decree 1010 - what has changed in Indonesia?
(Click on the image for a larger version)
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- Europe’s cancer community publishes new report on transforming patient care
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- ASH 2022: bad blood but big advances
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- Alzheimer’s Society urges UK government to deliver on dementia plan
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Sanofi backs vaccines unit with €350m Canadian facility
- World Health Organization releases latest set of COVID-19 guidelines
- Omnichannel communications in Medical Affairs: closing the gap between aspiration and reality
PMHub
The Good Ideas Group
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...
